INSIDER
Eli Lilly’s antibody combination receives FDA emergency use authorization to treat COVID-19 patients
Read full article: Eli Lilly’s antibody combination receives FDA emergency use authorization to treat COVID-19 patientsFILE - This is an April 26, 2017, file photo showing Eli Lilly corporate headquarters in Indianapolis. Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized patients. The drugmaker said Tuesday, Oct. 27, 2020, that It remains confident that its drug may stop COVID from developing in other patients. (AP Photo/Darron Cummings, File)HOUSTON – Eli Lilly’s announced Tuesday the approval by the U.S. Food and Drug Administration (FDA) of Emergency Use Authorization (EUA) for its combination antibody therapy. Lilly will collaborate with the bio-tech company Amgen to manufacture up to one million doses of etesevimab for administration with bamlanivimab by mid-2021.
COVID-19 at-home test: What you need to know about the Kroger test just approved by the FDA
Read full article: COVID-19 at-home test: What you need to know about the Kroger test just approved by the FDAHOUSTON The U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization for the Kroger brands COVID-19 Test Home Collection Kit, the grocery chain announced Wednesday. Heres how Kroger Healths COVID-19 Test Home Collection Kit works, as described by the company:The home collection is performed under the supervision of a licensed healthcare professional. Upon receipt of the home collection kit, a healthcare professional guides the home collection process via telehealth a two-way video chat. The direct observation helps to ensure the proper technique is used for sample collection. If test results are negative for an active infection, results are released to the patients electronic medical record portal.